Dynamic Axial Chirality in Drug Design and Discovery: Introduction to Atropisomerism, Classification, Significance, Recent Trends and Challenges

dc.contributor.authorJoshi, Gaurav
dc.contributor.authorKaur, Manpreet
dc.contributor.authorKumar, Raj
dc.date.accessioned2024-01-21T10:38:16Z
dc.date.accessioned2024-08-13T12:05:10Z
dc.date.available2024-01-21T10:38:16Z
dc.date.available2024-08-13T12:05:10Z
dc.date.issued2021-02-18T00:00:00
dc.description.abstractInduction of chirality in non-chiral ligands via involvement of hindered rotation around a single bond has led to the development of atropisomers. The atropisomers behave similarly as the chiral compounds and impact the drug discovery process. The chapter deals importantly with the brief introduction to this class, nomenclature descriptors, methods to measure atropisomers racemization, and the impact of atropisomers on drug discovery and includes relevant examples of drugs both from synthetic and natural origin. The chapter further extends to deal with various methodologies involved in atropselective conversions and regulatory guidelines involved in the development of atropisomers. � Springer Nature Singapore Pte Ltd. 2021.en_US
dc.identifier.doi10.1007/978-981-15-5534-3_4
dc.identifier.isbn9789811555343
dc.identifier.isbn9789811555336
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/3513
dc.identifier.urlhttps://link.springer.com/10.1007/978-981-15-5534-3_4
dc.language.isoen_USen_US
dc.publisherSpringer Singaporeen_US
dc.subjectAtropisomerismen_US
dc.subjectAtropisomersen_US
dc.subjectBiaryl linkageen_US
dc.subjectChiral drug developmenten_US
dc.subjectDynamic axial chiralityen_US
dc.subjectProatropisomericen_US
dc.titleDynamic Axial Chirality in Drug Design and Discovery: Introduction to Atropisomerism, Classification, Significance, Recent Trends and Challengesen_US
dc.title.journalDrug Discovery and Development: From Targets and Molecules to Medicinesen_US
dc.typeBook chapteren_US
dc.type.accesstypeClosed Accessen_US

Files